Rogers, Gabriel; Garside, Ruth; Mealing, Stuart; Pitt, … - In: PharmacoEconomics 26 (2008) 1, pp. 33-44
Compared with usual care for the treatment of newly diagnosed high-grade gliomas, BCNU-W is unlikely to be considered a cost-effective use of healthcare resources when judged by the standards commonly adopted in England and Wales. However, the dreadful prognosis of the condition and the paucity...